Farmaceutische specialiteiten op basis van tocilizumab
Closed
The source does not publish a status. We worked this out from the opening and closing dates it does publish.
Farmaceutische specialiteiten op basis van tocilizumab
- Status
- Closed
- Procedure
- OPEN
- Deadline
- Published
- Country
- Belgium
- Funder
- Healthcare Public Procurement
- Official page
- Open at the source portal
What applying involved
2 steps, all of them taken from this call's own documents.
This call is closed. The steps below show what applying involved, and are kept for reference only.
Understand the call
- Read the call on the source portal and download its documents
Submit
- Submit before the closing date shown above
Similar opportunities
- Farmaceutische specialiteiten op basis van denosumab
- Farmaceutische specialiteiten op basis van deferasirox
- farmaceutische specialiteiten op basis van intraveneus toegediend rituximab
- Farmaceutische preparaten op basis van infliximab IV
- Spécialité pharmaceutique à base d'immunoglobulines issues du plasma humain à administration IV
- Farmaceutisch preparaat op basis van 1 g paracetamol IV
Where this came from
- Source document
- https://www.publicprocurement.be/api/sea/search/publications?publicationDate=2026-09-16&page=2&pageSize=200
- Document fingerprint
d8c79800b9e97ab2(SHA-256, first 16 hex characters)- Collected
- First recorded here
What has changed
- url first recorded as https://www.publicprocurement.be/publication-workspaces/da370b9b-f840-4cea-8541-f3b0ee3e0f55/general on
- deadline first recorded as 2026-10-19 on
- published_on first recorded as 2026-09-16 on
- procedure_type first recorded as OPEN on
- status_basis first recorded as derived_window on
- status first recorded as open on
- title first recorded as Farmaceutische specialiteiten op basis van tocilizumab on
Data source
Source: Bulletin des Adjudications / Bulletin der Aanbestedingen — BOSA e-Procurement.
We collected this from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.